The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 2 of the 26 sources its claims cite were checked for support.
CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α
Open accessAbstract
BACKGROUND AND AIMS: Psychological stress is a predisposing factor in the onset and exacerbation of important gastrointestinal diseases including irritable bowel syndrome (IBS) and the inflammatory bowel diseases (IBD). The pathophysiology of stress-induced intestinal disturbances is known to be mediated by corticotropin releasing factor (CRF) but the precise signaling pathways remain poorly understood. Utilizing a porcine ex vivo intestinal model, the aim of this study was to investigate the mechanisms by which CRF mediates intestinal epithelial barrier disturbances. METHODOLOGY: Ileum was harvested from 6-8 week-old pigs, mounted on Ussing Chambers, and exposed to CRF in the presence or absence of various pharmacologic inhibitors of CRF-mediated signaling pathways. Mucosal-to-serosal flux of 4 kDa-FITC dextran (FD4) and transepithelial electrical resistance (TER) were recorded as indices of intestinal epithelial barrier function. RESULTS: Exposure of porcine ileum to 0.05-0.5 µM CRF increased (p<0.05) paracellular flux compared with vehicle controls. CRF treatment had no deleterious effects on ileal TER. The effects of CRF on FD4 flux were inhibited with pre-treatment of tissue with the non-selective CRF(1/2) receptor antagonist Astressin B and the mast cell stabilizer sodium cromolyn (10(-4) M). Furthermore, anti-TNF-α neutralizing antibody (p<0.01), protease inhibitors (p<0.01) and the neural blocker tetrodotoxin (TTX) inhibited CRF-mediated intestinal barrier dysfunction. CONCLUSION: These data demonstrate that CRF triggers increases in intestinal paracellular permeability via mast cell dependent release of TNF-α and proteases. Furthermore, CRF-mast cell signaling pathways and increases in intestinal permeability require critical input from the enteric nervous system. Therefore, blocking the deleterious effects of CRF may address the enteric signaling of mast cell degranulation, TNFα release, and protease secretion, hallmarks of IBS and IBD.
Overview
CoChat Summary
TL;DR
Using an ex vivo porcine ileum Ussing chamber model, the paper shows that CRF increases paracellular permeability without changing TER. The barrier effect depends on mast cell degranulation, TNF-α and protease activity, and requires enteric neural signaling.
Key findings
- CRF at 0.05, 0.1, and 0.5 µM increased FD4 flux across porcine ileal mucosa compared with vehicle controls (p<0.05), but did not affect TER over 180 min.
- Astressin B (1 µM) prevented CRF-induced increases in FD4 flux, indicating CRF receptor-mediated effects.
- 0.5 µM CRF induced mast cell degranulation and increased release of mast cell tryptase and TNF-α; sodium cromolyn (10−4 M) blocked mast cell degranulation, FD4 flux increases, and TNF-α elevation.
- Protease inhibitors and anti-TNF-α each inhibited CRF-stimulated FD4 flux (p<0.01), and TTX blocked both baseline and CRF-mediated mast cell degranulation and FD4 flux.
Methods
- Ex vivo study using ileum from 6–8 week-old pigs mounted in Ussing chambers; tissues were exposed to CRF with or without pharmacologic inhibitors.
- Barrier function was assessed by mucosal-to-serosal FD4 flux and transepithelial electrical resistance (TER); additional readouts included histology, mast cell degranulation counts, TNF-α ELISA, tryptase assay, and occludin immunofluorescence.
- Statistical analysis used one-way ANOVA with Fisher’s LSD post hoc test; mast cell counts used the Mann-Whitney test.
Limitations
- The paper states that the pharmacologic approach could not distinguish whether CRF effects were mediated by direct mast cell receptor activation or indirectly via enteric neurons, because CRF receptors are expressed on both.
- The authors note they could not discern which specific mast cell proteases were responsible because the protease inhibitor cocktail contained inhibitors of both tryptase and chymase.
- Evident from the text: the work is an ex vivo porcine ileum model, so the findings are not direct in vivo or human clinical evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
0 Valid · 0 Not valid · 14 Not checked · 28 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“a critical event in the onset of clinical symptoms of GI disorders including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) [7], [8], [9], [10]”
§ CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α > Introduction
What the sources say
- Could not verifycites [7] A Aggarwal, 1994, Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities., Gastroenterology sourceExperimental — accuracy not yet measured
Our full-text copy of Aggarwal et al. (1994) is entirely about autonomic function (vagal cholinergic RR1, sympathetic adrenergic PAR/VC), radiopaque-marker colon transit and MMPI/MBHI/SIP psychological profiles in 21 IBS patients; no passage mentions intestinal permeability, gut barrier, or inflammatory bowel disease (searched: 'intestinal permeability critical event onset clinical symptoms', 'permeability lactulose mannitol gut barrier tight junction inflammation', 'pathophysiology hypothesis'). The Introduction (p. 1) frames pathophysiology only in terms of motor disorder, psychological factors and autonomic imbalance ('the overall pathophysiology of the disorder is not well understood'), so it neither supports nor contradicts a permeability claim. Absence of the point is not grounds for disputed, and the paper credits no other work for a permeability finding, so misattribution cannot be established either. (LLM, conf=0.75)
- Could not verifycites [8] EJ Bennett, 1998, Level of chronic life stress predicts clinical outcome in irritable bowel syndrome., Gut sourceExperimental — accuracy not yet measured
Our copy of Bennett et al. (1998, Gut) is entirely a prospective study of chronic life stress threat and subsequent symptom intensity/clinical outcome in 117 IBS/FD outpatients (Abstract; Discussion; Table 3); nothing in it addresses intestinal permeability, barrier function, or inflammatory bowel disease. Searches for 'intestinal permeability' and 'gut barrier permeability / mucosal inflammation' returned only stress-outcome passages and reference lists, and the paper's patients were required to have 'absence of organic disease by appropriate investigations' (PATIENTS section), so IBD/permeability mechanisms are outside its scope. The claim attributed to this citation is therefore not checkable against our copy. (LLM, conf=0.70)
- Not checked yetcites [9] MM Delvaux, 1999, Stress and visceral perception.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pre-treatment of porcine ileal tissues with the mast cell stabilizing agent, sodium cromolyn (10−4 M), blocked CRF-mediated mast cell degranulation (Figures 5, 6C) and increases in FD4 flux (Figure 6D).”
§ CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α > Results > Mast Cell Degranulation is required for CRF-mediated Increases in Paracellular Permeability in the Porcine Ileum
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Under baseline condition (no CRF), PI and the higher anti-TNF-α (10 µg/mL) reduced baseline FD4 flux indicating the influence of proteases and TNF-α under basal conditions.”
§ CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α > Results > Blockade of TNF-α and Protease Activity Prevents CRF-induced Gut Barrier Dysfunction
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“protease inhibitors (p<0.01) and the neural blocker tetrodotoxin (TTX) inhibited CRF-mediated intestinal barrier dysfunction.”
- Also stated in: § Blockade of TNF-α and Protease Activity Prevents CRF-induced Gut Barrier Dysfunction · plain
“Protease inhibitors (PI) and anti-TNF-α (0.1 and 10 µg/mL) inhibited CRF-stimulated elevations in FD4 flux (Figure 7A–B).”
§ CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α > Abstract > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Blockade of TNF-α and Protease Activity Prevents CRF-induced Gut Barrier Dysfunction · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Histological analysis revealed no disruption of intestinal epithelial continuity with CRF (0.5 µM) treatment (Figure 3) indicating that the effects of CRF were due to alterations in the paracellular flux pathways rather than destruction of the epithelium.”
§ CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α > Results > Influence of CRF on Porcine Ileal Intestinal Barrier Function
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims
Create a free account to see all 42 claims and to verify the 24 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blocking CRF restrains the development of IBD by inhibiting mast cell degranulation and reducing tumor necrosis factor-alpha (TNF-α) and protease production (27).”
From Stress triggers flare of inflammatory bowel disease in children and adults (2019) · cites this paper as [27]
In the citing paper
“Furthermore, increases in sensory receptor expression, nerve hyperplasia, systemic inflammatory reactions, and stress may also contribute to IC/BPS [33].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [33]
Citations
Cites
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Ma, T. Y., Iwamoto, G. K., Hoa, N. T., Akotia, V., Pedram, A., Boivin, M. A., & Said, H. M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00173.2003 · Cited by 909
Tight Junction Pore and Leak Pathways: A Dynamic Duo
Shen, L., Weber, C. R., Raleigh, D. R., Yu, D., & Turner, J. R. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142150 · Cited by 872
Mast cell-orchestrated immunity to pathogens
Abraham, S. N., & St. John, A. L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2782 · Cited by 837
Restoration of Barrier Function in Injured Intestinal Mucosa
Blikslager, A. T., Moeser, A. J., Gookin, J. L., Jones, S. L., & Odle, J. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2006 · Cited by 574
Self-citationEarly weaning stress impairs development of mucosal barrier function in the porcine intestine
Smith, F., Clark, J. E., Overman, B. L., Tozel, C. C., Huang, J. H., Rivier, J. E. F., Blisklager, A. T., & Moeser, A. J. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00081.2009 · Cited by 500
Self-citationMarchiando, A. M., Shen, L., Graham, W. V., Weber, C. R., Schwarz, B. T., Austin, J. R., Raleigh, D. R., Guan, Y., Watson, A. J. M., Montrose, M. H., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200902153 · Cited by 477
Neuropeptides activate human mast cell degranulation and chemokine production
Kulka, M., Sheen, C. H., Tancowny, B. P., Grammer, L. C., & Schleimer, R. P. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02705.x · Cited by 445
Level of chronic life stress predicts clinical outcome in irritable bowel syndrome
Bennett, E. J., Tennant, C. C., Piesse, C., Badcock, C.-A., & Kellow, J. E. (1998) · Gut · doi:10.1136/gut.43.2.256 · Cited by 405
Mast Cell Tryptase Controls Paracellular Permeability of the Intestine
Jacob, C., Yang, P.-C., Darmoul, D., Amadesi, S., Saito, T., Cottrell, G. S., Coelho, A.-M., Singh, P., Grady, E. F., Perdue, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506338200 · Cited by 334
Cited by
The vagus nerve at the interface of the microbiota-gut-brain axis
Bonaz, B., Bazin, T., & Pellissier, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00049 · Cited by 1,397
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110
“Corticotrophin releasing factor (CRF) and its receptors (CRFR1 and CRFR2), play a key role in stress-induced gut permeability dysfunction (Overman et al., 2012; RodiñoJaneiro et al., 2015; Taché and Million, 2015).”
BackgroundBrain–Gut Interactions in Inflammatory Bowel Disease
Bonaz, B. L., & Bernstein, C. N. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.10.003 · Cited by 667
Petra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., & Theoharides, T. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.002 · Cited by 592
The role of inflammation and the gut microbiome in depression and anxiety
Peirce, J. M., & Alviña, K. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24476 · Cited by 466
Metadata
- Authors
- Overman, E. L., Rivier, J. E., & Moeser, A. J.
- Affiliations
- North Carolina State University (US)
- Salk Institute for Biological Studies (US)
- Corresponding author
- Moeser, Adam J.
- ORCID
- Moeser, Adam J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-29
- Volume
- 7
- Issue
- 6
- Pages
- e39935
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3386952
- OpenAlex
- W2125432409
- Cited by
- 207
- References
- 52
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 10 · 2023: 18 · 2022: 17 · 2021: 13 · 2020: 19 · 2019: 17 · 2018: 17 · 2017: 26 · 2016: 12 · 2015: 14 · 2014: 15 · 2013: 8 · 2012: 3
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (DK-34987)
- U.S. Public Health Service (DKPO1026741)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK084313, P30‐DK34987, P30DK034987)
- Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina at Chapel Hill (P30 DK34987, DK34987)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Keywords
- corticotropin-releasing factor, psychological stress, intestinal epithelial barrier, intestinal permeability, mast cell degranulation, mast cell proteases, TNF-α, enteric nervous system, tetrodotoxin, irritable bowel syndrome, inflammatory bowel disease, porcine ileum, transepithelial electrical resistance
- MeSH terms
- Animals, Corticotropin-Releasing Hormone, Dextrans, Ileum, Intestinal Mucosa, Mast Cells, Molecular Weight, Neutralization Tests, Peptide Fragments, Peptide Hydrolases, Permeability, Protease Inhibitors, Tumor Necrosis Factor-alpha, Cell Degranulation, Fluorescein-5-isothiocyanate, Enteric Nervous System, Protein Transport, Sus scrofa, Rats, Occludin, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α. https://app.cochat.ai/papers/10.1371/journal.pone.0039935
- The paper
- Overman, E. L., Rivier, J. E., & Moeser, A. J. (2012). CRF Induces Intestinal Epithelial Barrier Injury via the Release of Mast Cell Proteases and TNF-α. PLoS ONE. https://doi.org/10.1371/journal.pone.0039935
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.